NZ's Chatham Rock Phosphate extends gains, says no'adverse effect' from COVID-19

Chatham Rock Phosphate

25/05/2020 24:12

** Shares of Chatham Rock Phosphate Ltd  CRP.NZ  rise as
much as 1.5% to NZ$0.13, set for eighth straight session of
gains
    ** Mineral explorer confirms Covid-19 pandemic has not
adversely affected either co's operations or any of its team
 urn:newsml:reuters.com:*:nNZW2VYxq5
    ** Says co is actively looking at other phosphate assets
with a view to widen portfolio
    ** Adds, with respect to the Chatham Rise Phosphate project,
co is very confident the outcome of second application with the
New Zealand Environmental Protection Authority for a Marine
Consent will be successful
    ** Shares of co hit their highest level in more than three
months; biggest intraday pct gain nearly in a week
    ** Stock had dropped 29.4% this year, as of last close

 (Reporting by Deepali Saxena; Editing by Kim Coghill)
 ((Deepali.Saxena@thomsonreuters.com;))